Research Library

This report examines the societal and economic benefits of investing in children’s early brain development. It also assesses public child care, preschool, home-visiting and parenting education programs in Texas and makes recommendations for possible reforms.

In early 2017, Mayor Sylvester Turner appointed Baker Institute fellow Quianta Moore to his newly created Task Force on Equity, which was charged with developing actionable policy recommendations to make Houston a more equitable place to live.

The Advancing Care for Exceptional Kids Act proposes a national database that would serve as a centralized source of information on children with medically complex conditions. The aim is to improve treatment and care coordination. The authors of this brief argue, however, that the database could put children and their families at risk of discrimination by making their health information public, and therefore accessible to employers and health insurers.

Children with medical complexity (CMC), defined as children who have chronic medical conditions that can be expected to last at least one year and to require speciality pediatric care, depend on technology and multiple providers for their acute and daily health needs. The authors explore how the use of telemedicine, coupled with a patient-centered medical home model of care, can improve the efficacy and efficiency of care for CMC.

In order to increase the capacity of American children to become productive citizens and compete in a global economy, it is vital that future federal policies include a focus on improving children’s brain development, writes health policy scholar Quianta Moore.

Increasingly, stakeholders from diverse sectors acknowledge there is a window of opportunity early in life in which the brain is particularly susceptible to effective interventions with measurable long-term benefits. The authors undertook this paper with the principal purpose of setting priorities for investment in early childhood brain development.

The "molecular autopsy," or the collection of blood and tissue for DNA analysis, is an increasingly pervasive tool in investigating sudden death in the young. The authors offer recommendations that address ethical and policy issues that arise when molecular autopsies are conducted as part of a death investigation by medical examiner or coroner offices.

Health Policy Scholar Quianta Moore examines legal and ethical justifications for permitting high-risk adolescents to consent to HIV prevention therapy in the Health Policy Forum’s March 2016 newsletter.

The second largest percentage of new HIV infections in the United States occurs among people aged 13 to 24 years old. Yet very few state minor consent laws explicitly authorize adolescents to consent to preventive services for HIV and other sexually transmitted infections without parental permission.